Miragen Therapeutics

$1.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-8.13%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell MGEN and other stocks, options, ETFs, and crypto commission-free!

About MGEN

Miragen Therapeutics, Inc. Common Stock, also called Miragen Therapeutics, is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Read More Its product pipelines include MRG-106 that focuses on the treatment of blood cancer; and MRG-201 deals with the treatment of pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Boulder, CO.

Employees
80
Headquarters
Boulder, Colorado
Founded
2006
Market Cap
35.08M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
759.00K
High Today
$1.24
Low Today
$1.07
Open Price
$1.24
Volume
271.56K
52 Week High
$6.34
52 Week Low
$0.7777

Collections

MGEN Earnings

-$0.38
-$0.31
-$0.25
-$0.18
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.